Your browser doesn't support javascript.
loading
2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice.
Rodríguez-Carrio, Javier; Burska, Agata; Conaghan, Philip G; Dik, Willem A; Biesen, Robert; Eloranta, Maija-Leena; Cavalli, Giulio; Visser, Marianne; Boumpas, Dimitrios T; Bertsias, George; Wahren-Herlenius, Marie; Rehwinkel, Jan; Frémond, Marie-Louise; Crow, Mary K; Rönnblom, Lars; Versnel, Marjan A; Vital, Edward M.
Affiliation
  • Rodríguez-Carrio J; Department of Functional Biology, University of Oviedo, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Asturias, Spain.
  • Burska A; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds & NIHR Leeds Biomedical Research Centre, Leeds, UK.
  • Conaghan PG; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds & NIHR Leeds Biomedical Research Centre, Leeds, UK.
  • Dik WA; Erasmus MC, University Medical Center Rotterdam, Laboratory Medical Immunology, Department of Immunology, Rotterdam, The Netherlands.
  • Biesen R; Charité University Medicine Berlin, Department of Rheumatology, Berlin, Germany.
  • Eloranta ML; Uppsala University, Department of Medical Sciences, Rheumatology, Uppsala, Sweden.
  • Cavalli G; Vita-Salute San Raffaele University, Unit of Immunology, Rheumatology, Allergy and Rare Diseases, Milan, Italy.
  • Visser M; EULAR PARE Patient Research Partner, Amsterdam, The Netherlands.
  • Boumpas DT; Medicine, University of Crete, Medical School, Department of Internal Medicine, Heraklion, Greece.
  • Bertsias G; University of Crete, Medical School, Department of Rheumatology-Clinical Immunology, Heraklion, Greece.
  • Wahren-Herlenius M; Karolinska Institutet, Division of Rheumatology, Stockholm, Sweden.
  • Rehwinkel J; Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Frémond ML; Medical Research Council Human Immunology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Crow MK; Université de Paris Cité, Hôpital Necker-Enfants Malades, Immuno-Hématologie et Rhumatologie pédiatriques, Paris, France.
  • Rönnblom L; Hospital for Special Surgery, Weill Cornell Medical College, Mary Kirkland Center for Lupus Research, New York, New York, USA.
  • Versnel MA; Uppsala University, Department of Medical Sciences, Rheumatology, Uppsala, Sweden.
  • Vital EM; Erasmus MC, University Medical Center Rotterdam, Department of Immunology, Rotterdam, The Netherlands.
Ann Rheum Dis ; 82(6): 754-762, 2023 06.
Article in En | MEDLINE | ID: mdl-36858821
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rheumatology / Musculoskeletal Diseases Type of study: Prognostic_studies Limits: Humans Language: En Journal: Ann Rheum Dis Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rheumatology / Musculoskeletal Diseases Type of study: Prognostic_studies Limits: Humans Language: En Journal: Ann Rheum Dis Year: 2023 Document type: Article Affiliation country: Country of publication: